Latest 23andMe Stories
Individuals who send off saliva samples to genetic testing companies to determine whether or not they are at risk for diabetes or certain forms of cancer may receive different results depending on which company they select.
23andMe, Inc., a leading personal genetics company, announced today that it has published the first data to come out of its novel participant-driven research program.
The Food and Drug Administration is cracking down on 23andMe, as well as other companies that sell genetic tests directly to consumers.
Lawmakers said on Wednesday that a House of Representatives committee is investigating personal genetic testing kits after one company attempted to sell its test through retailers.
NEW YORK, Oct.
MOUNTAIN VIEW, Calif., Oct. 13 /PRNewswire/ -- 23andMe, Inc., an industry leader in personal genetics, conducted the genetic analysis of both former and current NFL players, as well as scientific controls, to investigate how genes impact athletic performance.
SANTA MONICA, Calif., Oct. 12 /PRNewswire-USNewswire/ -- Arthur D.
SANTA MONICA, Calif., Aug. 3 /PRNewswire-USNewswire/ -- Genentech Board Chairman Arthur D.
Genetic testing is being brought to the masses by a young US start-up business full of medical research veterans, with an affordable, comprehensive DNA service for the public.
With just $399 and a bit of saliva in a cup, consumers can learn about their genetic risk for diseases from breast cancer to diabetes.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.